Diagnosis, Assessment, and Treatment of Non-Pulmonary Arterial Hypertension Pulmonary Hypertension

被引:340
作者
Hoeper, Marius M. [1 ]
Barbera, Joan Albert [2 ]
Channick, Richard N. [3 ]
Hassoun, Paul M. [4 ]
Lang, Irene M. [5 ]
Manes, Alessandra [6 ]
Martinez, Fernando J. [7 ]
Naeije, Robert [8 ]
Olschewski, Horst [9 ]
Pepke-Zaba, Joanna [10 ]
Redfield, Margaret M. [11 ]
Robbins, Ivan M. [12 ]
Souza, Rogerio [13 ]
Torbicki, Adam [14 ]
McGoon, Michael [15 ]
机构
[1] Leibniz Univ Hannover, Sch Med, Dept Resp Med, Hannover, Germany
[2] Univ Barcelona, Dept Resp Med, Hosp Clin, CIBERES, Barcelona, Spain
[3] Univ Calif San Diego, Div Pulm & Crit Care Med, La Jolla, CA 92093 USA
[4] Johns Hopkins Univ, Sch Med, Dept Med Pulm & Crit Care Med, Baltimore, MD USA
[5] Med Univ Vienna, Div Cardiol, Vienna, Austria
[6] Univ Bologna, Inst Cardiol, Bologna, Italy
[7] Univ Michigan Hlth Syst, Div Pulm & Crit Care Med, Ann Arbor, MI USA
[8] Free Univ Brussels, Dept Pathophysiol, Brussels, Belgium
[9] Med Univ Graz, Dept Pulmonol, Graz, Austria
[10] Papworth Hosp, Pulm Vasc Dis Unit, Cambridge CB3 8RE, England
[11] Mayo Clin, Dept Cardiol, Rochester, MN USA
[12] Vanderbilt Univ, Med Ctr, Dept Allergy Pulm & Crit Care Med, Nashville, TN USA
[13] Univ Sao Paulo, Dept Pulm, Inst Heart, Sch Med, Sao Paulo, Brazil
[14] Med Univ Warsaw, Inst TB & Lung Dis, Dept Chest Med, Warsaw, Poland
[15] Mayo Clin, Dept Cardiovasc Med, Rochester, MN USA
关键词
diagnosis; assessment; non-PAH pulmonary hypertension; CHRONIC HEART-FAILURE; INHALED NITRIC-OXIDE; VENTRICULAR EJECTION FRACTION; RANDOMIZED CONTROLLED TRIAL; BRAIN NATRIURETIC PEPTIDE; OBSTRUCTIVE LUNG-DISEASE; EXERCISE CAPACITY; DOPPLER ECHOCARDIOGRAPHY; EPOPROSTENOL THERAPY; VASCULAR-RESISTANCE;
D O I
10.1016/j.jacc.2009.04.008
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
The 4th World Symposium on Pulmonary Hypertension was the first international meeting to focus not only on pulmonary arterial hypertension (PAH) but also on the so-called non-PAH forms of pulmonary hypertension (PH). The term "non-PAH PH" summarizes those forms of PH that are found in groups 2 to 5 of the current classification of PH, that is, those forms associated with left heart disease, chronic lung disease, recurrent venous thromboembolism, and other diseases. Many of these forms of PH are much more common than PAH, but all of them have been less well studied, especially in terms of medical therapy. The working group on non-PAH PH focused mainly on 4 conditions: chronic obstructive lung disease, interstitial lung disease, chronic thromboembolic PH, and left heart disease. The medical literature regarding the role of PH in these diseases was reviewed, and recommendations regarding diagnosis and treatment of PH in these conditions are provided. Given the lack of robust clinical trials addressing PH in any of these conditions, it is important to conduct further studies to establish the role of medical therapy in non-PAH PH. (J Am Coll Cardiol 2009;54:S85-96) (C) 2009 by the American College of Cardiology Foundation
引用
收藏
页码:S85 / S96
页数:12
相关论文
共 100 条
[1]
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications - An analysis from the Acute Decompensated Heart Failure National Registry (ADHERE) [J].
Abraham, WT ;
Adams, KF ;
Fonarow, GC ;
Costanzo, MR ;
Berkowitz, RL ;
LeJemtel, TH ;
Cheng, ML ;
Wynne, J .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (01) :57-64
[2]
PULMONARY-HYPERTENSION PREDICTS MORTALITY AND MORBIDITY IN PATIENTS WITH DILATED CARDIOMYOPATHY [J].
ABRAMSON, SV ;
BURKE, JF ;
KELLY, JJ ;
KITCHEN, JG ;
DOUGHERTY, MJ ;
YIH, DF ;
MCGEEHIN, FC ;
SHUCK, JW ;
PHIAMBOLIS, TP .
ANNALS OF INTERNAL MEDICINE, 1992, 116 (11) :888-895
[3]
Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease [J].
Arcasoy, SM ;
Christie, JD ;
Ferrari, VA ;
Sutton, MS ;
Zisman, DA ;
Blumenthal, NP ;
Pochettino, A ;
Kotloff, RM .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (05) :735-740
[4]
CHRONIC MAJOR-VESSEL THROMBOEMBOLIC PULMONARY-ARTERY OBSTRUCTION - APPEARANCE AT ANGIOGRAPHY [J].
AUGER, WR ;
FEDULLO, PF ;
MOSER, KM ;
BUCHBINDER, M ;
PETERSON, KL .
RADIOLOGY, 1992, 182 (02) :393-398
[5]
Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease [J].
Barbera, JA ;
Roger, N ;
Roca, J ;
Rovira, I ;
Higenbottam, TW ;
RodriguezRoisin, R .
LANCET, 1996, 347 (8999) :436-440
[6]
Updated Evidence-Based Treatment Algorithm in Pulmonary Arterial Hypertension [J].
Barst, Robyn J. ;
Gibbs, J. Simon R. ;
Ghofrani, Hossein A. ;
Hoeper, Marius M. ;
McLaughlin, Vallerie V. ;
Rubin, Lewis J. ;
Sitbon, Olivier ;
Tapson, Victor F. ;
Galie, Nazzareno .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (01) :S78-S84
[7]
Pulmonary hypertension in interstitial lung disease [J].
Behr, J. ;
Ryu, J. H. .
EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (06) :1357-1367
[8]
Accuracy of MR angiography compared with radionuclide scanning in identifying the cause of pulmonary arterial hypertension [J].
Bergin, CJ ;
Hauschildt, J ;
Rios, G ;
Belezzuoli, EV ;
Huynh, T ;
Channick, RN .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1997, 168 (06) :1549-1555
[9]
BLANCO I, 2008, EUR RESPIR J, V32, pS167
[10]
Bonderman D, 2005, CHEST, V128, P2599, DOI 10.1378/chest.128.4.2599